FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023366466> ?p ?o ?g. }

• W2023366466 endingPage "2842" @default.
• W2023366466 startingPage "2834" @default.
• W2023366466 abstract "Fragile X syndrome (FXS) results from dynamic mutations leading ultimately to the absence of expression of the Fragile X Mental Retardation Protein (FMRP). It is characterized by synaptic upregulated protein synthesis and immature dendritic spines associated with altered brain plasticity and cognitive functions. Recent work in Fmr1 knockout mice has shown that lovastatin, an inhibitor of Ras-ERK1/2, normalized hippocampus protein synthesis. We hypothesize that lovastatin, as a disease-modifying drug, would counterweigh the absence of FMRP and improve behavior. Here we report a phase I study to assess the safety and efficacy of lovastatin in individuals with FXS. A total of 15 patients (13 males, 6-31 years old) were treated with escalating doses of lovastatin (up to 40 mg) for three months. Their behavior were assessed before and after treatment using the Aberrant Behavioral Checklist--Community (ABC-C) total score (primary outcome), as well as domains of the FXS validated version of the ABC-C (secondary outcomes). The treatment was well tolerated and minimal side effects were reported. Significant improvement in the primary outcome (P<0.005), as well as in secondary outcomes, were observed in the majority of the subjects (12/15). We think that long-term sustained treatment with diseased-modifying drugs would be necessary in order to improve behavior and ultimately learning. Lovastatin, well known for its long-term security profile, would be a good candidate for that purposes. Our study showing reassuring safety data along with potential functional benefit emphasizes the need of a placebo-controlled trial to ascertain lovastatin efficacy in FXS individuals." @default.
• W2023366466 created "2016-06-24" @default.
• W2023366466 creator A5039670040 @default.
• W2023366466 creator A5065781051 @default.
• W2023366466 creator A5073013936 @default.
• W2023366466 creator A5077006982 @default.
• W2023366466 creator A5080909011 @default.
• W2023366466 date "2014-09-24" @default.
• W2023366466 modified "2023-09-27" @default.
• W2023366466 title "Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open-label study" @default.
• W2023366466 cites W1710017602 @default.
• W2023366466 cites W1934245552 @default.
• W2023366466 cites W1970072674 @default.
• W2023366466 cites W1979516671 @default.
• W2023366466 cites W1979757230 @default.
• W2023366466 cites W2008658806 @default.
• W2023366466 cites W2011527537 @default.
• W2023366466 cites W2026734721 @default.
• W2023366466 cites W2038338205 @default.
• W2023366466 cites W2040982838 @default.
• W2023366466 cites W2044352563 @default.
• W2023366466 cites W2047636274 @default.
• W2023366466 cites W2054410092 @default.
• W2023366466 cites W2055911520 @default.
• W2023366466 cites W2065077390 @default.
• W2023366466 cites W2068373068 @default.
• W2023366466 cites W2069351669 @default.
• W2023366466 cites W2071482305 @default.
• W2023366466 cites W2076834039 @default.
• W2023366466 cites W2092491372 @default.
• W2023366466 cites W2101716121 @default.
• W2023366466 cites W2103709346 @default.
• W2023366466 cites W2115110458 @default.
• W2023366466 cites W2116276594 @default.
• W2023366466 cites W2118934429 @default.
• W2023366466 cites W2125608178 @default.
• W2023366466 cites W2125639599 @default.
• W2023366466 cites W2140382995 @default.
• W2023366466 cites W2149919973 @default.
• W2023366466 cites W2150200318 @default.
• W2023366466 cites W2153053291 @default.
• W2023366466 cites W2156319664 @default.
• W2023366466 cites W2418221041 @default.
• W2023366466 doi "https://doi.org/10.1002/ajmg.a.36750" @default.
• W2023366466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25258112" @default.
• W2023366466 hasPublicationYear "2014" @default.
• W2023366466 type Work @default.
• W2023366466 sameAs 2023366466 @default.
• W2023366466 citedByCount "60" @default.
• W2023366466 countsByYear W20233664662015 @default.
• W2023366466 countsByYear W20233664662016 @default.
• W2023366466 countsByYear W20233664662017 @default.
• W2023366466 countsByYear W20233664662018 @default.
• W2023366466 countsByYear W20233664662019 @default.
• W2023366466 countsByYear W20233664662020 @default.
• W2023366466 countsByYear W20233664662021 @default.
• W2023366466 countsByYear W20233664662022 @default.
• W2023366466 countsByYear W20233664662023 @default.
• W2023366466 crossrefType "journal-article" @default.
• W2023366466 hasAuthorship W2023366466A5039670040 @default.
• W2023366466 hasAuthorship W2023366466A5065781051 @default.
• W2023366466 hasAuthorship W2023366466A5073013936 @default.
• W2023366466 hasAuthorship W2023366466A5077006982 @default.
• W2023366466 hasAuthorship W2023366466A5080909011 @default.
• W2023366466 hasConcept C104317684 @default.
• W2023366466 hasConcept C118552586 @default.
• W2023366466 hasConcept C126322002 @default.
• W2023366466 hasConcept C134018914 @default.
• W2023366466 hasConcept C142724271 @default.
• W2023366466 hasConcept C170493617 @default.
• W2023366466 hasConcept C187212893 @default.
• W2023366466 hasConcept C204787440 @default.
• W2023366466 hasConcept C27081682 @default.
• W2023366466 hasConcept C2777630245 @default.
• W2023366466 hasConcept C2778163477 @default.
• W2023366466 hasConcept C2779063550 @default.
• W2023366466 hasConcept C2780940807 @default.
• W2023366466 hasConcept C3020422209 @default.
• W2023366466 hasConcept C54355233 @default.
• W2023366466 hasConcept C71924100 @default.
• W2023366466 hasConcept C86803240 @default.
• W2023366466 hasConcept C98229152 @default.
• W2023366466 hasConceptScore W2023366466C104317684 @default.
• W2023366466 hasConceptScore W2023366466C118552586 @default.
• W2023366466 hasConceptScore W2023366466C126322002 @default.
• W2023366466 hasConceptScore W2023366466C134018914 @default.
• W2023366466 hasConceptScore W2023366466C142724271 @default.
• W2023366466 hasConceptScore W2023366466C170493617 @default.
• W2023366466 hasConceptScore W2023366466C187212893 @default.
• W2023366466 hasConceptScore W2023366466C204787440 @default.
• W2023366466 hasConceptScore W2023366466C27081682 @default.
• W2023366466 hasConceptScore W2023366466C2777630245 @default.
• W2023366466 hasConceptScore W2023366466C2778163477 @default.
• W2023366466 hasConceptScore W2023366466C2779063550 @default.
• W2023366466 hasConceptScore W2023366466C2780940807 @default.
• W2023366466 hasConceptScore W2023366466C3020422209 @default.
• W2023366466 hasConceptScore W2023366466C54355233 @default.
• W2023366466 hasConceptScore W2023366466C71924100 @default.

• next